definiens: means all Patent Rights Controlledby [COMPANY] or its Affiliates on the Effective Date or at any time during the Term Covering ( a ) thecomposition of matter of a Product, ( b ) methods of using a Product, or ( c ) an oligonucleotidecompound that specifically modulates expression of a Target via the binding, partially or wholly, of such compound to RNA that encodes a Target ; provided, however, that Patent RightsControlled by [COMPANY] or any of its Affiliates to the extent that such Patent Rights include anyclaims that are directed to ( i ) subject matter applicable to oligonucleotide compounds or productsin general or ( ii ) an oligonucleotide compound that does not specifically modulate expression ofa Target via the binding, partially or wholly, of such compound to RNA that encodes a Target, willnot be considered [COMPANY] Product - Specific Patents, and in the case of ( i ) and ( ii ), such claims insuch Patent Rights will be considered [COMPANY] Core Technology Patents . The [COMPANY] Product - Specific Patent Rights as of the Effective Date are set forth on Schedule 1.13 attached hereto